Publikationer
2026
Ninja Overgaard, Kjersti Lia, Jeremia Collin, Peter H. Asdahl, Per Wikman, Ingrid Glimelius, Ingemar Lagerlöf, Ann-Sofie Johansson, Lotta Hansson, Gunilla Enblad, Johan Linderoth, Christina Goldkuhl, Urban Jerlstrom, Alexander Fossa, Peter Kamper, Daniel Molin
(2026)
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma
Blood Advances, Vol. 10, s. 4889-4897
(Artikel i tidskrift)
https://dx.doi.org/10.1182/bloodadvances.2025018954
2025
David J. Lewis, Mats Jerkeman, Lexy Sorrell, David Wright, Ingrid Glimelius, Annika Pasanen, Christian B. Poulsen, Andrew Rawstron, Karin F. Wader, Nick Morley, Catherine Burton, Andrew J. Davies, Ingemar Lagerlöf, Surita Dalal, Ruth De Tute, Chris McNamara, Nicola Crosbie, Helle Erbs Toldbod, Jeanette Sanders, Victoria Allgar, Sree Aroori, Mark Warner, Claire Scully, Brian Wainman, Jacob Haaber Christensen, Jon Riise, Kristina Sonnevi, Mark J. Bishton, Toby A. Eyre, Simon Rule
(2025)
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
The Lancet, Vol. 406, s. 1953-1968
(Artikel i tidskrift)
https://dx.doi.org/10.1016/S0140-6736(25)01432-1
Mats Jerkeman, Karin Mellgren, Kristina Sonnevi, Mikael Lisak, Ingemar Lagerlöf, Balazs Kapas, Hanna Sjoelund, Jacek Toporski, Hans Hagberg, Stephan Mielke, Gunilla Enblad
(2025)
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden
Leukemia, Vol. 39, s. 1256-1259
(Artikel i tidskrift)
https://dx.doi.org/10.1038/s41375-025-02573-y
2021
Bjoern Engelbrekt Wahlin, Ninja Overgaard, Stefan Peterson, Evangelos Digkas, Ingrid Glimelius, Ingemar Lagerlöf, Ann-Sofie Johansson, Marzia Palma, Lotta Hansson, Johan Linderoth, Christina Goldkuhl, Daniel Molin
(2021)
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years
eJHaem, Vol. 2, s. 400-412
(Artikel i tidskrift)
https://dx.doi.org/10.1002/jha2.202